<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(1)</volume><submitter>Sugimoto A</submitter><pubmed_abstract>Signaling lymphocytic activation molecule family member 8 (SLAMF8) / B-lymphocyte activator macrophage expressed/CD353 is a member of the CD2 family. SLAMF8 suppresses macrophage function but enhances the growth of neoplastic mast cells via SHP-2. In this study, we found that some anaplastic large cell lymphoma (ALCL) samples were immunohistochemically positive for SLAMF8. However, we found no significant differences between SLAMF8-positive and SLAMF8-negative ALCL samples with respect to age, gender, site, or prognosis. We also identified SLAMF8 expression in ALCL cell lines, Karpas299, and SU-DHL-1. SLAMF8 knockdown decreased the activation of SHP-2 and the growth of these cell lines, and increased the apoptosis of these cell lines. In addition, we observed the interaction between SLAMF8</pubmed_abstract><journal>Scientific reports</journal><pagination>2505</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7018816</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>SLAM family member 8 is expressed in and enhances the growth of anaplastic large cell lymphoma.</pubmed_title><pmcid>PMC7018816</pmcid><pubmed_authors>Moriyoshi K</pubmed_authors><pubmed_authors>Kataoka TR</pubmed_authors><pubmed_authors>Kitamura K</pubmed_authors><pubmed_authors>Saito N</pubmed_authors><pubmed_authors>Sugimoto A</pubmed_authors><pubmed_authors>Hirata M</pubmed_authors><pubmed_authors>Ueshima C</pubmed_authors><pubmed_authors>Takaori-Kondo A</pubmed_authors><pubmed_authors>Ito H</pubmed_authors><pubmed_authors>Otsuka Y</pubmed_authors><pubmed_authors>Nishikori M</pubmed_authors><pubmed_authors>Takei Y</pubmed_authors><pubmed_authors>Haga H</pubmed_authors></additional><is_claimable>false</is_claimable><name>SLAM family member 8 is expressed in and enhances the growth of anaplastic large cell lymphoma.</name><description>Signaling lymphocytic activation molecule family member 8 (SLAMF8) / B-lymphocyte activator macrophage expressed/CD353 is a member of the CD2 family. SLAMF8 suppresses macrophage function but enhances the growth of neoplastic mast cells via SHP-2. In this study, we found that some anaplastic large cell lymphoma (ALCL) samples were immunohistochemically positive for SLAMF8. However, we found no significant differences between SLAMF8-positive and SLAMF8-negative ALCL samples with respect to age, gender, site, or prognosis. We also identified SLAMF8 expression in ALCL cell lines, Karpas299, and SU-DHL-1. SLAMF8 knockdown decreased the activation of SHP-2 and the growth of these cell lines, and increased the apoptosis of these cell lines. In addition, we observed the interaction between SLAMF8</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Feb</publication><modification>2025-04-25T21:07:34.06Z</modification><creation>2020-05-22T10:42:50Z</creation></dates><accession>S-EPMC7018816</accession><cross_references><pubmed>32054954</pubmed><doi>10.1038/s41598-020-59530-1</doi></cross_references></HashMap>